Analyst stock forecast
Exagen Forecast: $10.14 Analyst Target
Direct answer
Exagen's average price target is $10.14.
The target implies +22.2% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies +8.4%, the high target implies +44.6%, and the range spans 36.1% of the current price.
Forecast evidence checked September 30, 2026.
Get free Exagen email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $8.30
- Average price target
- $10.14
- High price target
- $12.00
- Low price target
- $9.00
- Low target gap
- +8.4%
- Target upside
- +22.2%
- High target gap
- +44.6%
- Target range width
- 36.1%
- Consensus rating
- Strong Buy
- Analysts
- 7
- Evidence date
- September 30, 2026
- Valid through
- October 7, 2026
Explore related company data
Read the frequently asked questions.
What is Exagen's average price target?
Exagen's verified average price target is $10.14. The target range is $9.00 to $12.00.
How far are Exagen's low and high targets from the recorded price?
The low target implies +8.4%, while the high target implies +44.6%.
How many analysts are included in Exagen's consensus?
The verified consensus includes 7 analysts.
How is Exagen's target upside or downside calculated?
The average target of $10.14 is divided by the recorded price of $8.30, then one is subtracted to produce +22.2%. This does not guarantee a future return.
When was Exagen's analyst forecast verified?
The data was verified on 2026-09-30. The dataset is valid through 2026-10-07.